216 related articles for article (PubMed ID: 14745551)
1. Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder.
Birlik M; Akar S; Tuzel E; Onen F; Ozer E; Manisali M; Kirkali Z; Akkoc N
J Cancer Res Clin Oncol; 2004 Feb; 130(2):122-5. PubMed ID: 14745551
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of lymph-node dissection in patients undergoing radical cystectomy following previous oncological treatment for bladder cancer.
Jensen JB; Ulhøi BP; Jensen KM
Scand J Urol Nephrol; 2011 Dec; 45(6):436-43. PubMed ID: 21854099
[TBL] [Abstract][Full Text] [Related]
3. [The efficacy and toxicity of gemcitabine and cisplatin chemotherapy in advanced/metastatic bladder urothelial carcinoma].
Gunlusoy B; Arslan M; Vardar E; Degirmenci T; Kara C; Ceylan Y; Kozacıoğlu Z
Actas Urol Esp; 2012 Oct; 36(9):515-20. PubMed ID: 22819345
[TBL] [Abstract][Full Text] [Related]
4. Combined chemoradiotherapy with gemcitabine in patients with locally advanced inoperable transitional cell carcinoma of the urinary bladder and/or in patients ineligible for surgery: a phase I trial.
De Santis M; Bachner M; Cerveny M; Kametriser G; Steininger T; Königsberg R; Schratter-Sehn A; Sedlmayer F; Dittrich C
Ann Oncol; 2014 Sep; 25(9):1789-1794. PubMed ID: 24936582
[TBL] [Abstract][Full Text] [Related]
5. Synchronous solitary metastasis of transitional cell carcinoma of the bladder to the testis.
Morgan K; Srinivas S; Freiha F
Urology; 2004 Oct; 64(4):808-9. PubMed ID: 15491734
[TBL] [Abstract][Full Text] [Related]
6. Intravesical gemcitabine in recurrent superficial bladder carcinoma: preliminary results on ablative efficacy and tolerability.
Campodonico F; Canepa G; Capponi G; Bozzo L; Maffezzini M
Anticancer Res; 2005; 25(3c):2381-4. PubMed ID: 16080464
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine and cisplatin as neoadjuvant chemotherapy for invasive transitional and squamous cell carcinoma of the bladder: effect on survival and bladder preservation.
Khaled HM; Shafik HE; Zabhloul MS; Ghoneim M; Saber RA; Manie M; Enein HA; Megeed HA; Mansur O; Sherbini ME; Mahran TZ; Kalawee ME; Badran A; Ramadan SM
Clin Genitourin Cancer; 2014 Oct; 12(5):e233-40. PubMed ID: 24889794
[TBL] [Abstract][Full Text] [Related]
8. Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trial.
Oh KS; Soto DE; Smith DC; Montie JE; Lee CT; Sandler HM
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):511-7. PubMed ID: 18977098
[TBL] [Abstract][Full Text] [Related]
9. [Elevation of CA 19.9 in urothelial bladder cancer].
Bastos Oreiro M; López Rodríguez M; Monedero Martín MC; Plasencia Rodríguez C
Med Clin (Barc); 2008 Mar; 130(8):319. PubMed ID: 18358126
[No Abstract] [Full Text] [Related]
10. [A case of undifferentiated bladder carcinoma with axilla lymph node metastasis successfully treated with gemcitabine and cisplatin].
Takayanagi N; Chiba H; Sagawa T; Hirayama Y; Tsuji Y; Sakamaki S
Gan To Kagaku Ryoho; 2003 Dec; 30(13):2137-40. PubMed ID: 14712779
[TBL] [Abstract][Full Text] [Related]
11. Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study.
Böhle A; Leyh H; Frei C; Kühn M; Tschada R; Pottek T; Wagner W; Knispel HH; von Pokrzywnitzki W; Zorlu F; Helsberg K; Lübben B; Soldatenkova V; Stoffregen C; Büttner H;
Eur Urol; 2009 Sep; 56(3):495-503. PubMed ID: 19560257
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance.
Addeo R; Caraglia M; Bellini S; Abbruzzese A; Vincenzi B; Montella L; Miragliuolo A; Guarrasi R; Lanna M; Cennamo G; Faiola V; Del Prete S
J Clin Oncol; 2010 Feb; 28(4):543-8. PubMed ID: 19841330
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer.
Shelley M; Cleves A; Wilt TJ; Mason M
Cochrane Database Syst Rev; 2011 Apr; (4):CD008976. PubMed ID: 21491413
[TBL] [Abstract][Full Text] [Related]
14. [Cerebral vasculitis associated with gemcitabine].
Schmorl P; Heer-Sonderhoff A; Vosshenrich R; Conrad S
Urologe A; 2010 Feb; 49(2):268-70. PubMed ID: 20213928
[TBL] [Abstract][Full Text] [Related]
15. Toxic epidermal necrolysis associated with gemcitabine therapy in a patient with metastatic transitional cell carcinoma of the bladder.
Mermershtain W; Cohen AD; Lazarev I; Grunwald M; Ariad S
J Chemother; 2003 Oct; 15(5):510-1. PubMed ID: 14598945
[TBL] [Abstract][Full Text] [Related]
16. [Bladder preservation possibilities in the treatment of muscle-invasive bladder cancer].
Asadauskiene J; Aleknavicius E; Zelviene TP; Jankevicius F
Medicina (Kaunas); 2006; 42(10):781-7. PubMed ID: 17090976
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant Chemotherapy for Patients with Muscle-invasive Urothelial Bladder Cancer Candidates for Curative Surgery: A Prospective Clinical Trial Based on Cisplatin Feasibility.
Schinzari G; Monterisi S; Pierconti F; Nazzicone G; Marandino L; Orlandi A; Racioppi M; Cassano A; Bassi P; Barone C; Rossi E
Anticancer Res; 2017 Nov; 37(11):6453-6458. PubMed ID: 29061832
[TBL] [Abstract][Full Text] [Related]
18. Expression of nucleoside transporters and deoxycytidine kinase proteins in muscle invasive urothelial carcinoma of the bladder: correlation with pathological response to neoadjuvant platinum/gemcitabine combination chemotherapy.
North S; El-Gehani F; Santos C; Ghosh S; Lai R; Cass CE; Mackey JR
J Urol; 2014 Jan; 191(1):35-9. PubMed ID: 23851183
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancer.
Galsky MD; Hahn NM; Powles T; Hellerstedt BA; Lerner SP; Gardner TA; Yu M; O'Rourke M; Vogelzang NJ; Kocs D; McKenney SA; Melnyk AM; Hutson TE; Rauch M; Wang Y; Asmar L; Sonpavde G
Clin Genitourin Cancer; 2013 Jun; 11(2):175-81. PubMed ID: 23228446
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.
Dalbagni G; Russo P; Sheinfeld J; Mazumdar M; Tong W; Rabbani F; Donat MS; Herr HW; Sogani P; dePalma D; Bajorin D
J Clin Oncol; 2002 Aug; 20(15):3193-8. PubMed ID: 12149290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]